Areas of Interest
My scientific interest is primarily focused on the role of endoplasmic reticulum (ER)-associated protein degradation (ERAD) and ER homeostasis. I am currently investigating the (patho-) physiological significance of ERAD mutations in humans in Dr. Ling Qi’s laboratory. Our overall goal is to pave the foundation for future effort to therapeutically target ERAD complex in the treatment of various ERAD-related diseases.
Honors & Awards
- National Ataxia Foundation (NAF) Post-Doctoral Fellowship (2022-2023)
- Poster Presentation Award 1st Place at 2022 Michigan Postdoctoral Pioneer Program Symposium (2022)
- Elected Ph.D. graduate speaker at the graduation ceremony (2019)
- Ph.D., Biochemistry and Molecular Biology, Shanghai Institutes of Biological Sciences, CAS.
Published Articles or Reviews
- Liangguang Lin, Congcong Zhang, Yongwu Chen, Yi Wang, Dinghe Wang, Xiaolei Liu, Muyang Wang, Juan Mao, Jianjun Zhang, Weiman Xing, Linchuan Liu, Jianming Li. PAWH1 and PAWH2 are plant-specific components of an Arabidopsis endoplasmic reticulum-associated degradation complex. 2019 Nature Communications. DOI: 10.1038/s41467-019-11480-7
- Sei Yoshida, Xiaoqiong Wei, Gensheng Zhang, Christopher L. O’Connor, Mauricio Torres, Zhangsen Zhou, Liangguang Lin, Rajasree Menon, Xiaoxi Xu, Wenyue Zheng, Yi Xiong, Edgar Otto, Chi-Chi Anthony Tang, Rui Hua, Rakesh Verma, Hiroyuki Mori, Yang Zhang, Chih-Chi Andrew Hu, Ming Liu, Puneet Garg, Jeffrey B. Hodgin, Shengyi Sun, Markus Bitzer, and Ling Qi (2021). “Endoplasmic reticulum-associated degradation is required for nephrin maturation and kidney glomerular filtration function.” The Journal of Clinical Investigation 1;131(7):e143988. PMID: 33591954